Screening patients for Barrett esophagus

Why, who, and how

Liam Zakko, Kavel Visrodia, Cadman Leggett, Lori Lutzke, Kenneth Ke Ning Wang

Research output: Contribution to journalReview article

Abstract

Although esophageal adenocarcinoma is an uncommon cancer, it is often fatal unless found at an early disease stage. Screening to discover early stage disease for its only known precursor, Barrett esophagus, is currently the only solution to improve survival. Multiple strategies have been suggested for screening including identification of a higher risk population using epidemiological factors such as sex, age, symptoms of reflux, and presence of central obesity. In addition, new nonendoscopic methods of screening have been created including sponges, balloons, breath tests, and tests on various bodily fluids. All of these new developments were created in order to improve the efficacy and cost-effectiveness of screening. New technologies may allow for a low-cost, noninvasive screening technology that is highly acceptable to healthy patients at risk for esophageal cancer.

Original languageEnglish (US)
Pages (from-to)55-61
Number of pages7
JournalTechniques in Gastrointestinal Endoscopy
Volume20
Issue number2
DOIs
StatePublished - Apr 1 2018

Fingerprint

Barrett Esophagus
Technology
Breath Tests
Abdominal Obesity
Porifera
Esophageal Neoplasms
Cost-Benefit Analysis
Adenocarcinoma
Costs and Cost Analysis
Survival
Population
Neoplasms

Keywords

  • Balloon cytology
  • Barrett esophagus
  • Breath test
  • Risk factors
  • Screening

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Screening patients for Barrett esophagus : Why, who, and how. / Zakko, Liam; Visrodia, Kavel; Leggett, Cadman; Lutzke, Lori; Wang, Kenneth Ke Ning.

In: Techniques in Gastrointestinal Endoscopy, Vol. 20, No. 2, 01.04.2018, p. 55-61.

Research output: Contribution to journalReview article

@article{d5f38b5911ad4e27a84d42d91d171761,
title = "Screening patients for Barrett esophagus: Why, who, and how",
abstract = "Although esophageal adenocarcinoma is an uncommon cancer, it is often fatal unless found at an early disease stage. Screening to discover early stage disease for its only known precursor, Barrett esophagus, is currently the only solution to improve survival. Multiple strategies have been suggested for screening including identification of a higher risk population using epidemiological factors such as sex, age, symptoms of reflux, and presence of central obesity. In addition, new nonendoscopic methods of screening have been created including sponges, balloons, breath tests, and tests on various bodily fluids. All of these new developments were created in order to improve the efficacy and cost-effectiveness of screening. New technologies may allow for a low-cost, noninvasive screening technology that is highly acceptable to healthy patients at risk for esophageal cancer.",
keywords = "Balloon cytology, Barrett esophagus, Breath test, Risk factors, Screening",
author = "Liam Zakko and Kavel Visrodia and Cadman Leggett and Lori Lutzke and Wang, {Kenneth Ke Ning}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.tgie.2018.05.001",
language = "English (US)",
volume = "20",
pages = "55--61",
journal = "Techniques in Gastrointestinal Endoscopy",
issn = "1096-2883",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Screening patients for Barrett esophagus

T2 - Why, who, and how

AU - Zakko, Liam

AU - Visrodia, Kavel

AU - Leggett, Cadman

AU - Lutzke, Lori

AU - Wang, Kenneth Ke Ning

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Although esophageal adenocarcinoma is an uncommon cancer, it is often fatal unless found at an early disease stage. Screening to discover early stage disease for its only known precursor, Barrett esophagus, is currently the only solution to improve survival. Multiple strategies have been suggested for screening including identification of a higher risk population using epidemiological factors such as sex, age, symptoms of reflux, and presence of central obesity. In addition, new nonendoscopic methods of screening have been created including sponges, balloons, breath tests, and tests on various bodily fluids. All of these new developments were created in order to improve the efficacy and cost-effectiveness of screening. New technologies may allow for a low-cost, noninvasive screening technology that is highly acceptable to healthy patients at risk for esophageal cancer.

AB - Although esophageal adenocarcinoma is an uncommon cancer, it is often fatal unless found at an early disease stage. Screening to discover early stage disease for its only known precursor, Barrett esophagus, is currently the only solution to improve survival. Multiple strategies have been suggested for screening including identification of a higher risk population using epidemiological factors such as sex, age, symptoms of reflux, and presence of central obesity. In addition, new nonendoscopic methods of screening have been created including sponges, balloons, breath tests, and tests on various bodily fluids. All of these new developments were created in order to improve the efficacy and cost-effectiveness of screening. New technologies may allow for a low-cost, noninvasive screening technology that is highly acceptable to healthy patients at risk for esophageal cancer.

KW - Balloon cytology

KW - Barrett esophagus

KW - Breath test

KW - Risk factors

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85048198050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048198050&partnerID=8YFLogxK

U2 - 10.1016/j.tgie.2018.05.001

DO - 10.1016/j.tgie.2018.05.001

M3 - Review article

VL - 20

SP - 55

EP - 61

JO - Techniques in Gastrointestinal Endoscopy

JF - Techniques in Gastrointestinal Endoscopy

SN - 1096-2883

IS - 2

ER -